EndoCeutics Dr. Fernand Labrie, long before becoming CEO of EndoCeutics, discovered and developed medical castration with GnRH agonists, a breakthrough treatment that quickly replaced surgical castration back in the early 1980s. Along with other discoveries, he founded EndoResearch in 1985 to further his research. After billions in revenue from treatments developed…
Juan Diego Sr. Gutierrez, when we interviewed your father in 2010, he described to us the strong potential of the medical industry in Colombia in the future. Since that time, would you say that Siplas has been able to take advantage of that potential? And if so, how? Siplas has been growing…
maintenance Mr. O’Neill, you have been managing director of this company for 17 years. How have you evolved the business over that period? ESS was founded in 1991, and I joined the business in 1996. The company’s initial vision was to provide flexibility to the maintenance market in Ireland and its…
Steripack Mr. Moore, can you please introduce our readers to yourself and to SteriPack? SteriPack was founded in Clara, Ireland, in 1994. When I joined the organization 18 years ago, we had perhaps eight people on staff. Today, our headcount approaches 400. We have four production sites spread across Ireland, Poland,…
TranScrip Partners Senior Partner Dr Sree Haran has also participated in this interview. TranScrip Partners is by now a well-established player in the UK but a new player in Asia Pacific. Would you begin by introducing TranScrip Partners to our readers? Dr. Sree Haran: TranScrip Partners was founded in 2008, and differs…
TranScrip Partners Dr Bernadette Morris-Smith has also participated in this interview TranScrip Partners is by now a well-established player in the UK but a new player in Asia Pacific. Would you begin by introducing TranScrip Partners to our readers? Dr. Sree Haran: TranScrip Partners was founded in 2008, and differs from the…
market You established Menarini’s Irish affiliate in 1999. How have you seen the market evolve over these last 13 years? The major changes in the market have principally occurred in the last four or five years, rather than the previous ten. Generally speaking, the industry has always had a very strong…
Ipsen Czech Republic Ms. Hauser, you represent what is perhaps the last major generation of medical doctors in this country that left the medical field to join the pharmaceutical business. What do you find are the greatest differences between the Czech pharma industry you joined in 1993 with Wellcome, and the industry you…
Unipharm You recently switched from Novartis to Unipharm. Given the major differences in environment and portfolio, what was it about Unipharm in particular that attracted you and what are you bringing on board? Many of my friends and colleagues were surprised and asked me what the reason is for my move…
Aipm ukraine What was the market need that spawned the creation of AIPM in 2009 considering that there were already other trade associations in Ukraine that were representing the interests of international pharmaceutical companies? What was the vision for this association? The idea of establishing AIPM originated much before 2009 and it…
Ipsen Brazil In a past interview, you said that Ipsen is different than the “Big Pharmas” who have entered Brazil by acquisition. You’ve taken a different tack since arriving as one of the newer international companies to Brazil, and you have been here since ground zero in 2007. What prompted that initial…
See our Cookie Privacy Policy Here
